Special Drug Use Investigation of EYLEA for Myopic Choroidal Neovascularization
Phase of Trial: Phase IV
Latest Information Update: 20 Sep 2019
Price : $35 *
At a glance
- Drugs Aflibercept (Primary)
- Indications Choroidal neovascularisation
- Focus Adverse reactions
- Sponsors Bayer
- 20 Jan 2019 Status changed from active, no longer recruiting to completed.
- 12 Apr 2018 Planned number of patients changed from 300 to 353.
- 12 Apr 2018 Status changed from recruiting to active, no longer recruiting.